stock pickIBRXemail_stock_pick
IBRX Soars to 52-Week High on Game-Changing Trial Results!
# IBRX Soars to 52-Week High on Game-Changing Trial Results!
Read moreFeatured By
Research
In-depth company research, stock analysis, and market opportunities from the Smart Investors Daily research team.
# IBRX Soars to 52-Week High on Game-Changing Trial Results!
Read more# TLX: First U.S. Patient Dosed in Prostate Cancer Study! 【97†L20-L21†embed_image】 *Caption: A PET/CT scanner used for radiopharmaceutical imaging in prostate cancer.
Read more# Citigroup’s Bold Move: Xenon Inducement Grants Unveiled! ## Introduction Citigroup Inc. (NYSE: C) is a global banking powerhouse navigating a major transformation under CEO Jane…
Read more# VTGN: Urgent Investor Alert – Act Before Deadline! ## Overview VistaGen Therapeutics, Inc. (NASDAQ: **VTGN**) is a clinical-stage biopharmaceutical company focused on novel…
Read more# CORT Shares Plummet 50%: Investor Alert on FDA Response!
Read more# CM: Breakthrough Study on Custom Orthoses for Pain Relief!
Read more# IBM's Target Upgraded! Strong Cash Flow Ahead! ## Dividend Policy & History IBM has a long-standing commitment to returning cash to shareholders through a steady dividend.
Read more# TLSA: Don't Miss Tiziana's $8.8M Game-Changer!
Read more# Goldman Sachs Boosts MSFT Target Ahead of Earnings!
Read more# Act Now: VTGN Investors Face Class Action Deadline! ## Introduction VistaGen Therapeutics, Inc. (NASDAQ: VTGN) – a late-stage neuropharmaceutical developer – is under scrutiny…
Read more